ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-4 · 마지막 7월 21일
Non-Hodgkin Lymphoma, B-cell · CD19
Relapsed; Refractory · CD19
B-NHL; B-Non Hodgkin Lymphoma · CD19
Idiopathic Inflammatory Myopathies(IIM); Immune Thrombocytopenia(ITP) · CD19
Primary CNS Lymphoma · CD19
B-cell Acute Lymphoblastic Leukemia; B-cell Non Hodgkin Lymphoma · CD19
Leukemia, Lymphoblastic, Acute, Lymphoma · CD19
Large B-Cell Lymphoma (LBCL) · CD19
B-cell Acute Lymphoblastic Leukemia · CD19
Non-Hodgkin Lymphoma; B-cell Non-Hodgkin Lymphoma (B-NHL) · CD19
Relapsed and Refractory B Cell Lymphoma; Non-Hodgkin Lymphoma · CD20
B Cell Lymphoma; B Cell Leukemia · CD19
B Cell Lymphoma · CD20
Relapsed and Refractory; Lymphoid Hematological Malignancies · CD20
Langerhans Cell Histiocytosis · CD20
B-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · CD22
Hairy Cell Leukemia; Hairy Cell Leukemia Variant · CD22
Advanced Pancreatic Carcinoma · Advanced Pancreatic Carcinoma
Anaplastic Large Cell Lymphoma; Peripheral T Cell Lymphoma · CD30
Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms · CD3
96 / 177 페이지
구조모아 (StructureMoa)항암 chemical structure spider web
KRMediMoa한의학·한약재 임상·근거 데이터
갱신 기록 없음 · 14일 주기 · 방문 3,553 / 14,193